← Back to Search

Behavioural Intervention

Nutritional Counseling for Breast Cancer

N/A
Waitlist Available
Led By Lee Hong, MD, PhD
Research Sponsored by Scripps Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age greater than or equal to 18 years and less than 100 years
Diagnosis of early-stage triple-negative breast cancer, not on neoadjuvant systemic therapy at the time of enrollment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to study the gut microbiome in early-stage triple-negative breast cancer patients undergoing neoadjuvant treatment. The researchers will recruit 30 patients to compare the effects of a high-fiber

Who is the study for?
This trial is for up to 30 patients with early-stage triple-negative breast cancer (TNBC) who are undergoing neoadjuvant treatment. Participants should be willing to potentially change their diet and provide stool samples. Specific inclusion or exclusion criteria aren't provided.
What is being tested?
The study tests if a high-fiber diet, guided by nutritional counseling from a registered dietician, can positively affect the gut microbiota compared to just receiving an educational handout during cancer treatment.
What are the potential side effects?
Since this trial involves dietary changes rather than medication, side effects may include gastrointestinal discomfort due to increased fiber intake but are expected to be minimal.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am at least 18 years old but younger than 100.
Select...
I have early-stage triple-negative breast cancer and am not on initial treatment.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Stool microbiome 16S bacterial species and diversity
Secondary study objectives
Activity level as measured on Rapid Assessment of Physical Activity scale
Anxiety as measured on Generalized Anxiety Disorder-7 scale
Depression as measured on Patient Health Questionnaire-9 scale.
+4 more
Other study objectives
Tumor gene expression analysis using GeoMx spatial transcriptional profiling

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: High Fiber Dietary CounselingExperimental Treatment1 Intervention
Participants will receive usual standard of care for early-stage triple negative breast cancer and personalized nutritional counseling (initial 1 hour session with up to 2 30-minute follow-up sessions) on how to increase dietary fiber.
Group II: Educational HandoutActive Control1 Intervention
Participants will receive usual standard of care for early-stage triple negative breast cancer and an educational handout on increasing dietary fiber.

Find a Location

Who is running the clinical trial?

The Scripps Research InstituteOTHER
31 Previous Clinical Trials
10,432 Total Patients Enrolled
Scripps HealthLead Sponsor
58 Previous Clinical Trials
43,543 Total Patients Enrolled
2 Trials studying Breast Cancer
56 Patients Enrolled for Breast Cancer
San Diego State UniversityOTHER
167 Previous Clinical Trials
114,102 Total Patients Enrolled
2 Trials studying Breast Cancer
1,318 Patients Enrolled for Breast Cancer
~20 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top